# A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

> **NCT01514929** · PHASE1 · COMPLETED · sponsor: **Achaogen, Inc.** · enrollment: 64 (actual)

## Conditions studied

- Cardiac Effects in Normal Healthy Volunteers

## Interventions

- **DRUG:** ACHN-490 Injection
- **DRUG:** ACHN-490 Injection
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01514929
- **Lead sponsor:** Achaogen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** —
- **Final completion:** 2012-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2012-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514929, "A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01514929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*